Related Experiment Videos
[Chronic ergotism: spinal lesion and neuropathy].
M Sallansonnet-Froment1, E Guegan-Massardier, A Blohorn-Sense
1Département de Neurologie, Hôpital Charles Nicolle, Rouen.
Revue Neurologique
|September 30, 2004
Summary
Chronic ergotism, a rare condition, can manifest as spinal lesions and sciatic nerve neuropathy. Prompt treatment with calcium blockers led to complete recovery in a reported case.
Area of Science:
- Neurology
- Toxicology
Background:
- Chronic ergotism, a condition resulting from prolonged exposure to ergot alkaloids, is infrequently associated with neuropathologic manifestations.
- Methysergide, an ergot derivative, is used for migraine prophylaxis and can cause adverse effects.
Observation:
- A case report details a 40-year-old patient experiencing symptoms indicative of a spinal lesion.
- The patient also presented with neuropathy affecting the right sciatic nerve, specifically the internal and external popliteal nerves.
Findings:
- The patient's symptoms were attributed to methysergide ingestion.
- Complete recovery was achieved following treatment with calcium channel blockers.
Implications:
- Ergotism should be considered in the differential diagnosis of patients on ergot alkaloid therapy who exhibit unusual clinical presentations.
- This case highlights the potential for ergot alkaloid-induced neuropathy and the efficacy of calcium channel blockers in its management.